1. Home
  2. JCE vs CADL Comparison

JCE vs CADL Comparison

Compare JCE & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Core Equity Alpha Fund of Beneficial Interest

JCE

Nuveen Core Equity Alpha Fund of Beneficial Interest

N/A

Current Price

$15.32

Market Cap

269.0M

Sector

Finance

ML Signal

N/A

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

N/A

Current Price

$4.96

Market Cap

280.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JCE
CADL
Founded
N/A
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
269.0M
280.3M
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
JCE
CADL
Price
$15.32
$4.96
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$18.50
AVG Volume (30 Days)
31.6K
1.2M
Earning Date
01-01-0001
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$125,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.51
$4.25
52 Week High
$16.31
$9.08

Technical Indicators

Market Signals
Indicator
JCE
CADL
Relative Strength Index (RSI) 34.82 42.30
Support Level $15.28 $4.48
Resistance Level $15.98 $6.16
Average True Range (ATR) 0.22 0.22
MACD -0.04 0.01
Stochastic Oscillator 13.55 38.76

Price Performance

Historical Comparison
JCE
CADL

About JCE Nuveen Core Equity Alpha Fund of Beneficial Interest

Nuveen Core Equity Alpha Fund is a diversified closed-end management investment company. Its investment objective is to provide an attractive level of total return, through long-term capital appreciation and through income and gains. The Fund invests in a portfolio of actively managed large-capitalization U.S. common stocks, using the sub-adviser's proprietary quantitative process designed to provide the potential for long-term outperformance. Additionally, the Fund seeks to reduce the volatility of its returns relative to the returns of the Equity Portfolio over extended periods by writing (selling) index call options and/or call options on custom baskets of securities.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: